Loading organizations...
Wuxi Venture Capital Group operates as a municipal-level investment firm, focusing its capital on promising science and technology enterprises. The firm provides equity and venture capital, along with management consulting, to foster innovation. Its strategic approach involves identifying and supporting high-growth potential companies within its geographical remit, aiming to accelerate their development through financial backing and expert guidance.
Established in 2000, Wuxi Venture Capital Group was formed as one of the earliest municipal-level venture capital institutions in Wuxi, China. Its inception was driven by an insight into the critical need for risk investment and development support for nascent science and technology ventures in the region. This foundational mandate positioned the group as a key enabler for local industrial and technological advancement.
The group primarily serves innovative entrepreneurs and burgeoning science and technology companies seeking early-stage funding and strategic partnership. Its vision centers on empowering these ventures to achieve their full potential, thereby contributing to the economic and technological growth of the Wuxi area. Wuxi Venture Capital Group remains committed to cultivating a robust ecosystem for local entrepreneurial success.
WuXi Venture has 2 tracked investments across 2 companies. The latest tracked deal is $17.5M Series B in XWPharma 凯瑞康宁 in September 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 20, 2017 | XWPharma 凯瑞康宁 | $17.5M Series B | Elements Capital, WI Harper Group | Johnson & Johnson Innovation, KPCB China, KTB Network |
| Dec 9, 2014 | Adagene | $8.0M Series A | — | Fidelity Management & Research Company, F Prime Capital |